A citation-based method for searching scientific literature

A E Holland, C J Hill, M Conron, P Munro, C F McDonald. Thorax 2008
Times Cited: 228







List of co-cited articles
922 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
52

Pulmonary rehabilitation for interstitial lung disease.
Leona Dowman, Catherine J Hill, Anne E Holland. Cochrane Database Syst Rev 2014
213
50

Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.
Osamu Nishiyama, Yasuhiro Kondoh, Tomoki Kimura, Keisuke Kato, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Shinichi Arizono, Koichi Nishimura, Hiroyuki Taniguchi. Respirology 2008
166
46

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.
Martijn A Spruit, Sally J Singh, Chris Garvey, Richard ZuWallack, Linda Nici, Carolyn Rochester, Kylie Hill, Anne E Holland, Suzanne C Lareau, William D-C Man,[...]. Am J Respir Crit Care Med 2013
41

Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study.
Christopher J Ryerson, Cindy Cayou, Fiona Topp, Lana Hilling, Pat G Camp, Pearce G Wilcox, Nasreen Khalil, Harold R Collard, Chris Garvey. Respir Med 2014
91
35

Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis.
Baruch Vainshelboim, Jose Oliveira, Liora Yehoshua, Israela Weiss, Benjamin Daniel Fox, Oren Fruchter, Mordechai Reuven Kramer. Respiration 2014
75
42

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
32

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
31

Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response.
Alicia Ferreira, Chris Garvey, Gerilynn L Connors, Lana Hilling, Julia Rigler, Susan Farrell, Cindy Cayou, Cyrus Shariat, Harold R Collard. Chest 2009
120
29

Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.
Baruch Vainshelboim, Jose Oliveira, Benjamin Daniel Fox, Yafit Soreck, Oren Fruchter, Mordechai Reuven Kramer. Lung 2015
60
45

The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
Leona M Dowman, Christine F McDonald, Catherine J Hill, Annemarie L Lee, Kathryn Barker, Claire Boote, Ian Glaspole, Nicole S L Goh, Anne M Southcott, Angela T Burge,[...]. Thorax 2017
113
27

Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease.
Patrick Huppmann, Bernd Sczepanski, Martina Boensch, Sandra Winterkamp, Ursula Schönheit-Kenn, Claus Neurohr, Juergen Behr, Klaus Kenn. Eur Respir J 2013
85
30

Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.
Anne E Holland, Catherine J Hill, Ian Glaspole, Nicole Goh, Christine F McDonald. Respir Med 2012
64
34

Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation.
Robert M Jackson, Orlando W Gómez-Marín, Carol F Ramos, Constanza M Sol, Meryl I Cohen, Ignacio A Gaunaurd, Lawrence P Cahalin, Diana D Cardenas. Lung 2014
46
45

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
21

An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.
Anne E Holland, Martijn A Spruit, Thierry Troosters, Milo A Puhan, Véronique Pepin, Didier Saey, Meredith C McCormack, Brian W Carlin, Frank C Sciurba, Fabio Pitta,[...]. Eur Respir J 2014
960
21

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
20


Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Ryo Kozu, Hideaki Senjyu, Sue C Jenkins, Hiroshi Mukae, Noriho Sakamoto, Shigeru Kohno. Respiration 2011
93
21

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
19

Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis.
Jeffrey J Swigris, Diane L Fairclough, Marianne Morrison, Barry Make, Elizabeth Kozora, Kevin K Brown, Frederick S Wamboldt. Respir Care 2011
59
28


Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
923
16

Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
Ganesh Raghu, Valeria C Amatto, Jürgen Behr, Susanne Stowasser. Eur Respir J 2015
201
16


Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosis.
Shinichi Arizono, Hiroyuki Taniguchi, Koji Sakamoto, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Osamu Nishiyama, Koichi Nishimura,[...]. Respir Care 2014
30
50

Ambulatory oxygen in interstitial lung disease.
D Visca, A Montgomery, A de Lauretis, P Sestini, H Soteriou, T M Maher, A U Wells, E A Renzoni. Eur Respir J 2011
70
20

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
David A Zisman, Marvin Schwarz, Kevin J Anstrom, Harold R Collard, Kevin R Flaherty, Gary W Hunninghake. N Engl J Med 2010
358
14

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
663
14

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
626
13

Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
Roland M du Bois, Derek Weycker, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Alex Kartashov, Lisa Lancaster, Paul W Noble, Steven A Sahn, Javier Szwarcberg,[...]. Am J Respir Crit Care Med 2011
270
13

Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.
David J Lederer, Selim M Arcasoy, Jessie S Wilt, Frank D'Ovidio, Joshua R Sonett, Steven M Kawut. Am J Respir Crit Care Med 2006
250
13

Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program.
Ignacio A Gaunaurd, Orlando W Gómez-Marín, Carol F Ramos, Constanza M Sol, Meryl I Cohen, Lawrence P Cahalin, Diana D Cardenas, Robert M Jackson. Respir Care 2014
44
29

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
Joyce S Lee, Harold R Collard, Kevin J Anstrom, Fernando J Martinez, Imre Noth, Rhonda S Roberts, Eric Yow, Ganesh Raghu. Lancet Respir Med 2013
247
13

Pulmonary rehabilitation for chronic obstructive pulmonary disease.
Bernard McCarthy, Dympna Casey, Declan Devane, Kathy Murphy, Edel Murphy, Yves Lacasse. Cochrane Database Syst Rev 2015
804
13

Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease.
Anne E Holland, Julio F Fiore, Emily C Bell, Nicole Goh, Glen Westall, Karen Symons, Leona Dowman, Ian Glaspole. Respirology 2014
80
16

A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.
David Weill, Christian Benden, Paul A Corris, John H Dark, R Duane Davis, Shaf Keshavjee, David J Lederer, Michael J Mulligan, G Alexander Patterson, Lianne G Singer,[...]. J Heart Lung Transplant 2015
721
13

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.
B Bradley, H M Branley, J J Egan, M S Greaves, D M Hansell, N K Harrison, N Hirani, R Hubbard, F Lake, A B Millar,[...]. Thorax 2008
492
12


Pirfenidone in idiopathic pulmonary fibrosis.
H Taniguchi, M Ebina, Y Kondoh, T Ogura, A Azuma, M Suga, Y Taguchi, H Takahashi, K Nakata, A Sato,[...]. Eur Respir J 2010
623
12

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.
Luca Richeldi, Vincent Cottin, Roland M du Bois, Moisés Selman, Toshio Kimura, Zelie Bailes, Rozsa Schlenker-Herceg, Susanne Stowasser, Kevin K Brown. Respir Med 2016
223
12

Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial.
Silvia Perez-Bogerd, Wim Wuyts, Veronica Barbier, Heleen Demeyer, Alain Van Muylem, Wim Janssens, Thierry Troosters. Respir Res 2018
43
27

Physical training for interstitial lung disease.
Anne Holland, Catherine Hill. Cochrane Database Syst Rev 2008
91
12


The SF-36 and SGRQ: validity and first look at minimum important differences in IPF.
Jeffrey J Swigris, Kevin K Brown, Juergen Behr, Roland M du Bois, Talmadge E King, Ganesh Raghu, Frederick S Wamboldt. Respir Med 2010
158
11

Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia.
Osamu Nishiyama, Hiroyuki Miyajima, Yumi Fukai, Ryo Yamazaki, Ryuji Satoh, Toshiyuki Yamagata, Hiroyuki Sano, Takashi Iwanaga, Yuji Higashimoto, Hirokazu Nakajima,[...]. Respir Med 2013
51
21

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
11

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.
Michael Kreuter, Wim Wuyts, Elisabetta Renzoni, Dirk Koschel, Toby M Maher, Martin Kolb, Derek Weycker, Paolo Spagnolo, Klaus-Uwe Kirchgaessler, Felix J F Herth,[...]. Lancet Respir Med 2016
127
11

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.
Imre Noth, Kevin J Anstrom, Sara Bristol Calvert, Joao de Andrade, Kevin R Flaherty, Craig Glazer, Robert J Kaner, Mitchell A Olman. Am J Respir Crit Care Med 2012
307
11

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Roland M du Bois, Elizabeth A Fagan, Robert S Fishman, Ian Glaspole, Marilyn K Glassberg, Lisa Lancaster,[...]. Eur Respir J 2016
223
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.